DOSE OF REALITY: OVERSIGHT REPORT EXPOSES BIG PHARMA’S EGREGIOUS PRICING & ANTI-COMPETITIVE TACTICS — DEBUNKS INNOVATION RHETORIC
Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top… Read More

Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top… Read More
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive… Read More
Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on… Read More
Brand Name Drug Executives Should Commit to Affordable Pricing on COVID-19… Read More
Part IV: Escalating Assault on 340B Program for Providers Serving America’s… Read More
Part III: Angling to Price-Gouge American Public on COVID-19 Treatments… Read More
Part II: Gaming the System to Undermine Competition at the Expense of American… Read More
Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic… Read More
Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More
Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More… Read More
Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering… Read More